Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannoma.
Bhattacharyya S, Oblinger JL, Beauchamp RL, Yin Z, Erdin S, Koundinya P, Ware AD, Ferrer M, Jordan JT, Plotkin SR, Xu L, Chang LS, Ramesh V.
Bhattacharyya S, et al.
Neuro Oncol. 2023 Sep 5;25(9):1617-1630. doi: 10.1093/neuonc/noad037.
Neuro Oncol. 2023.
PMID: 36806881
Free PMC article.